| |
| |
|
| Insider
Information: |
Went Gregory T |
| Relationship: |
Chief Executive Office... |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
232,541 |
|
|
Indirect Shares
|
199,242 |
|
|
| Direct
Value |
$1,911,487 |
|
|
|
Indirect Value
|
$1,637,769 |
|
|
| Total
Shares |
431,783 |
|
|
| Total
Value |
$3,549,256 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adamas Pharmaceuticals Inc |
ADMS |
Chief Executive Office... |
2019-04-08 |
232,541 |
2019-04-08 |
199,242 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
56,250 |
232,541 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-03-20 |
4 |
S |
$7.99 |
$50,489 |
D/D |
(6,319) |
176,291 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-11-07 |
4 |
B |
$12.98 |
$49,956 |
I/I |
3,850 |
199,242 |
2.66 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-03-21 |
4 |
S |
$25.75 |
$116,931 |
D/D |
(4,541) |
182,610 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,625 |
187,151 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-03-21 |
4 |
S |
$17.03 |
$47,803 |
D/D |
(2,807) |
166,526 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,125 |
169,333 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2016-10-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(195,400) |
195,392 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2016-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(117,450) |
146,208 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2016-06-15 |
4 |
OE |
$1.88 |
$384,188 |
D/D |
204,900 |
263,658 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2016-03-04 |
4 |
A |
$13.66 |
$392,725 |
D/D |
28,750 |
58,758 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-14 |
4 |
OE |
$1.88 |
$188 |
D/D |
100 |
30,108 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-14 |
4 |
AS |
$18.00 |
$1,800 |
D/D |
(100) |
30,008 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-14 |
4 |
AS |
$18.00 |
$3,600 |
I/I |
(200) |
390,792 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-13 |
4 |
AS |
$18.00 |
$1,800 |
I/I |
(100) |
390,992 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-13 |
4 |
AS |
$18.00 |
$504 |
D/D |
(28) |
30,008 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-13 |
4 |
OE |
$1.88 |
$18,803 |
D/D |
10,028 |
30,036 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-12 |
4 |
OE |
$1.88 |
$938 |
D/D |
500 |
20,508 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-12 |
4 |
AS |
$18.01 |
$9,003 |
D/D |
(500) |
20,008 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-05-12 |
4 |
AS |
$18.00 |
$32,400 |
I/I |
(1,800) |
391,092 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-04-23 |
4 |
AS |
$18.01 |
$43,212 |
I/I |
(2,400) |
392,892 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-04-23 |
4 |
AS |
$18.00 |
$16,200 |
D/D |
(900) |
20,008 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-04-23 |
4 |
OE |
$1.88 |
$1,688 |
D/D |
900 |
20,908 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-04-21 |
4 |
AS |
$18.00 |
$32,602 |
I/I |
(1,811) |
395,292 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Chief Executive Officer |
• • • |
2015-04-21 |
4 |
AS |
$18.01 |
$17,322 |
D/D |
(962) |
20,008 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
